Gastrin Producing Syngeneic Mesenchymal Stem Cells Protect Non-obese Diabetic Mice from Type 1 Diabetes

Scientists reported the use of MSCs for the production and delivery of Gastrin, a peptide hormone that is produced by intestinal cells and fetal islets and can increase β-cell mass, to promote protection from type 1 diabetes.